118 results
8-K/A
EX-99.1
ATOS
Atossa Therapeutics Inc
1 Apr 24
Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update
7:18pm
and per share data)
As of December 31,
Assets
Current assets
Cash and cash equivalents
Restricted cash
Prepaid materials
Prepaid expenses and other
8-K
EX-99.1
ATOS
Atossa Therapeutics Inc
1 Apr 24
Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update
4:00pm
data)
As of December 31,
Assets
Current assets
Cash and cash equivalents
Restricted cash
Prepaid materials
Prepaid expenses and other current assets
DEFA14A
oz6 zyh162s
26 Apr 23
Additional proxy soliciting materials
4:49pm
DEFA14A
rg8dpn23zovnte1a
14 Sep 21
Additional proxy soliciting materials
4:12pm